Owlet, Inc.
OWLTOwlet, Inc. in brief
Owlet, Inc. is a listed company in the Medical Devices industry, based in Lehi, Utah, USA. Its market value was $194 M on 1 August 2026, which makes it the 16,347th largest listed company in the world and the 3,171st largest in the USA on this site. In the year to December 2025 it had sales of $106 M and a net loss of $40 M. It employs about 108 people and Kurt Workman is its chief executive. By market, the largest shares of its 2025 sales came from USA (82%) and UK (6%). Its shares trade under the symbol OWLT (NYSE).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Owlet, Inc.
Owlet is a leading pediatric health platform and the only company globally to offer U.S. FDA-cleared and internationally medically-certified wearable pediatric monitors for home use. By delivering hospital-grade technology through a consumer-friendly interface, we bridge the critical gap between clinical care and the home.
Our ecosystem—comprising clinically tested monitoring systems, an integrated video platform, and an intuitive mobile app—supports families from "night one" and throughout the most challenging parts of the parenting journey. Since 2012, more than 2.5 million parents have trusted Owlet to provide the real-time insights in support of their child's well-being and to promote restful sleep for the entire family.
From the company's annual report filed with the US SEC: read the report
Owlet, Inc. timeline
- 2020
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 🔔Initial public offering as Sandbridge Acquisition CorpFinal prospectus filed with the SEC on 16 September 2020; shares registered for exchange trading on 14 September 2020. The blank-check company later merged with the business that carries the name today.
- 2021
- ✎Renamed Owlet, Inc.Formerly Sandbridge Acquisition Corp.
- 2025
- 💰Record revenue of $106 millionFY2025, the highest of the 6 years on record.
Events of Owlet, Inc. from SEC EDGAR and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #3,530 (Jan 2022) · #4,456 (Dec 2022) · #4,867 (Jul 2023) · #4,092 (Jan 2024) · #1,704 (Mar 2026) · #3,122 (Aug 2026)
Key ratios
- P/E ratio (TTM)
- n/m (loss)
- Price / sales (TTM)
- 1.7×
- Price / book
- 10.2×
- Free cash flow yield
- -5.7%
- Net margin (TTM)
- -8.5%
- Operating margin
- -7.8%
- Return on equity
- -50.8%
- Liabilities / assets
- 58.6%
- Net debt
- $-33M
- Revenue growth
- +35.4%
- R&D / revenue
- 13.3%
- Revenue per employee
- $979 K
- Profit per employee
- $-367 K
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $106M | +35.4% | $-8M | $-40M | -37.5% |
| Dec 2024 | $78M | +44.5% | $-20M | $-13M | -16.1% |
| Dec 2023 | $54M | -22.0% | $-29M | $-33M | -60.9% |
| Dec 2022 | $69M | -8.8% | $-85M | $-79M | -114.7% |
| Dec 2021 | $76M | +0.6% | $-56M | $-72M | -94.5% |
| Dec 2020 | $75M | — | $-7M | $-11M | -14.0% |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $-11M | $0M | $-11M | $-2.27 | — |
| Dec 2024 | $-11M | $0M | $-11M | $-1.57 | — |
| Dec 2023 | $-24M | $0M | $-24M | $-4.53 | — |
| Dec 2022 | $-81M | $1M | $-82M | $-9.98 | — |
| Dec 2021 | $-41M | $1M | $-42M | $-1.13 | — |
| Dec 2020 | $-0M | $1M | $-1M | $-0.48 | — |
Quarterly results
Latest quarter to Sep 2026: revenue $30M (-4.9% on a year earlier), net income $1M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Jun 2026.
SEC filings
- Aug 14, 20268-KCurrent reportDirectors or officers changed · Shareholder vote
- Aug 14, 202610-QQuarterly report · period to Jun 2026
- Aug 11, 20268-KCurrent reportResults of operations
- Jul 1, 20268-KCurrent reportMaterial agreement · New financial obligation
- Jun 30, 2026DEF 14AProxy statement
- Jun 5, 20268-KCurrent reportOther events
- May 11, 202610-QQuarterly report · period to Mar 2026
- May 7, 20268-KCurrent reportResults of operations
- Apr 30, 202610-K/AAnnual report (amended) · period to Dec 2025
- Apr 6, 20268-KCurrent reportDirectors or officers changed
- Mar 9, 202610-KAnnual report · period to Dec 2025
- Mar 5, 20268-KCurrent reportResults of operations
Official filings of Owlet, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- $106 M
- Operating income
- $-8 M
- Net income
- $-40 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $86 M
- Total liabilities
- $50 M
- Total equity
- $19 M
As of December-2025
Top 68 institutional investors in Owlet, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | Eclipse Operations, LLC | 7,700,835 | 0 (0.00%) | 26.35% | $41 M | Nov 9, 2026 |
| 2 | AWM Investment Company, Inc. | 1,793,164 | +567,811 (+46.34%) | 6.14% | $9 M | Nov 13, 2026 |
| 3 | Granahan Investment Management, LLC | 1,582,946 | -12,473 (-0.78%) | 5.42% | $8 M | Nov 16, 2026 |
| 4 | Cannell Capital LLC | 1,054,481 | -179,572 (-14.55%) | 3.61% | $6 M | Nov 16, 2026 |
| 5 | Vanguard Capital Management LLC | 716,972 | -84,746 (-10.57%) | 2.45% | $4 M | Nov 13, 2026 |
| 6 | Harbor Capital Advisors, Inc. | 392,687 | +62,751 (+19.02%) | 1.34% | $2 M | Oct 22, 2026 |
| 7 | Jacobs Levy Equity Management, Inc | 330,081 | -743 (-0.22%) | 1.13% | $2 M | Nov 16, 2026 |
| 8 | BlackRock, Inc. | 327,307 | -2,576 (-0.78%) | 1.12% | $2 M | Nov 13, 2026 |
| 9 | Meros Investment Management, LP | 302,709 | -24,403 (-7.46%) | 1.04% | $2 M | Nov 17, 2026 |
| 10 | Victory Capital Management Inc | 239,338 | New | 0.82% | $1 M | Nov 10, 2026 |
| 11 | Citadel Advisors LLC | 232,452 | -18,685 (-7.44%) | 0.80% | $1 M | Nov 16, 2026 |
| 12 | Geode Capital Management, LLC | 200,852 | -45,069 (-18.33%) | 0.69% | $1 M | Nov 6, 2026 |
| 13 | Man Group plc | 198,697 | +54,701 (+37.99%) | 0.68% | $1 M | Nov 16, 2026 |
| 14 | Portolan Capital Management, LLC | 167,563 | New | 0.57% | $1 M | Nov 16, 2026 |
| 15 | Renaissance Technologies LLC | 164,841 | -42,900 (-20.65%) | 0.56% | $1 M | Nov 12, 2026 |
| 16 | State of Wyoming | 148,634 | New | 0.51% | $1 M | Oct 28, 2026 |
| 17 | XTX Topco Ltd | 135,446 | -43,376 (-24.26%) | 0.46% | $1 M | Nov 16, 2026 |
| 18 | Gsa Capital Partners LLP | 117,180 | +101,416 (+643.34%) | 0.40% | $1 M | Nov 16, 2026 |
| 19 | Perkins Capital Management Inc | 116,075 | +9,580 (+9.00%) | 0.40% | $1 M | Nov 2, 2026 |
| 20 | Vanguard Fiduciary Trust Co | 111,754 | -27,212 (-19.58%) | 0.38% | $1 M | Nov 13, 2026 |
| 21 | State Street Corp | 111,111 | +5,600 (+5.31%) | 0.38% | $1 M | Nov 12, 2026 |
| 22 | Potomac Capital Management, Inc. | 83,500 | +6,080 (+7.85%) | 0.29% | $0 M | Nov 13, 2026 |
| 23 | Dimensional Fund Advisors LP | 72,700 | +15,366 (+26.80%) | 0.25% | $0 M | Nov 4, 2026 |
| 24 | Marshall Wace, LLP | 70,326 | -1,422 (-1.98%) | 0.24% | $0 M | Nov 13, 2026 |
| 25 | Colter Lewis Investment Partners LLC | 67,093 | 0 (0.00%) | 0.23% | $0 M | Nov 16, 2026 |
Show all 68: investors 26 to 68
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 26 | Morgan Stanley | 63,855 | +51,412 (+413.18%) | 0.22% | $0 M | Nov 13, 2026 |
| 27 | Goldman Sachs Group Inc | 57,288 | +30,468 (+113.60%) | 0.20% | $0 M | Nov 16, 2026 |
| 28 | Squarepoint Ops LLC | 56,930 | -41,261 (-42.02%) | 0.19% | $0 M | Nov 9, 2026 |
| 29 | Arax Advisory Partners | 52,192 | +23,486 (+81.82%) | 0.18% | $0 M | Nov 12, 2026 |
| 30 | Schonfeld Strategic Advisors LLC | 51,739 | New | 0.18% | $0 M | Nov 16, 2026 |
| 31 | Millennium Management LLC | 49,862 | -15,990 (-24.28%) | 0.17% | $0 M | Nov 16, 2026 |
| 32 | Northern Trust Corp | 46,086 | -7,812 (-14.49%) | 0.16% | $0 M | Nov 16, 2026 |
| 33 | UBS Group AG | 45,010 | -11,293 (-20.06%) | 0.15% | $0 M | Nov 10, 2026 |
| 34 | Dynamic Advisor Solutions LLC | 44,645 | 0 (0.00%) | 0.15% | $0 M | Oct 13, 2026 |
| 35 | MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 43,381 | -5,032 (-10.39%) | 0.15% | $0 M | Nov 16, 2026 |
| 36 | Point72 Asset Management, L.P. | 40,809 | New | 0.14% | $0 M | Nov 16, 2026 |
| 37 | Bridgeway Capital Management, LLC | 36,763 | -3,000 (-7.54%) | 0.13% | $0 M | Nov 16, 2026 |
| 38 | Occudo Quantitative Strategies LP | 33,756 | New | 0.12% | $0 M | Nov 16, 2026 |
| 39 | Empowered Funds, LLC | 33,725 | New | 0.12% | $0 M | Nov 13, 2026 |
| 40 | Algert Global LLC | 29,714 | New | 0.10% | $0 M | Nov 17, 2026 |
| 41 | Engineers Gate Manager LP | 26,666 | New | 0.09% | $0 M | Nov 16, 2026 |
| 42 | Ameriprise Financial Inc | 25,094 | -487,561 (-95.11%) | 0.09% | $0 M | Nov 16, 2026 |
| 43 | Susquehanna International Group, LLP | 25,003 | New | 0.09% | $0 M | Nov 16, 2026 |
| 44 | Mitsubishi UFJ Asset Management Co., Ltd. | 24,813 | -2,425 (-8.90%) | 0.08% | $0 M | Nov 5, 2026 |
| 45 | Bank Of America Corp /de/ | 19,269 | +1,680 (+9.55%) | 0.07% | $0 M | Nov 16, 2026 |
| 46 | Axq Capital, LP | 18,296 | New | 0.06% | $0 M | Nov 12, 2026 |
| 47 | HRT Financial LP | 16,245 | New | 0.06% | $0 M | Nov 13, 2026 |
| 48 | Jump Financial, LLC | 15,248 | New | 0.05% | $0 M | Nov 13, 2026 |
| 49 | BNP Paribas Financial Markets | 14,988 | -22,225 (-59.72%) | 0.05% | $0 M | Nov 12, 2026 |
| 50 | Qube Research & Technologies Ltd | 11,390 | New | 0.04% | $0 M | Nov 13, 2026 |
| 51 | Vanguard Global Advisers, LLC | 8,883 | 0 (0.00%) | 0.03% | $0 M | Nov 13, 2026 |
| 52 | Citigroup Inc | 3,108 | New | 0.01% | $0 M | Nov 4, 2026 |
| 53 | Avion Wealth | 2,500 | 0 (0.00%) | 0.01% | $0 M | Nov 4, 2026 |
| 54 | Barclays PLC | 1,987 | +1,592 (+403.04%) | 0.01% | $0 M | Nov 6, 2026 |
| 55 | Russell Investments Group, Ltd. | 1,448 | New | 0.01% | $0 M | Nov 6, 2026 |
| 56 | Clearstead Advisors, LLC | 1,442 | 0 (0.00%) | 0.00% | $0 M | Nov 6, 2026 |
| 57 | Mcguire Capital Advisors Inc | 1,190 | 0 (0.00%) | 0.00% | $0 M | Nov 16, 2026 |
| 58 | Global Retirement Partners, LLC | 1,014 | +1,000 (+7142.86%) | 0.00% | $0 M | Nov 10, 2026 |
| 59 | Wells Fargo & Company/mn | 670 | 0 (0.00%) | 0.00% | $0 M | Nov 16, 2026 |
| 60 | Royal Bank Of Canada | 537 | +512 (+2048.00%) | 0.00% | $0 M | Nov 16, 2026 |
| 61 | Group One Trading LLC | 104 | 0 (0.00%) | 0.00% | $0 M | Nov 10, 2026 |
| 62 | Jones Financial Companies Lllp | 100 | 0 (0.00%) | 0.00% | $0 M | Nov 13, 2026 |
| 63 | Signaturefd, LLC | 100 | 0 (0.00%) | 0.00% | $0 M | Oct 23, 2026 |
| 64 | Harborfront Financial Group LLC | 39 | New | 0.00% | $0 M | Nov 12, 2026 |
| 65 | Caitong International Asset Management Co., Ltd | 37 | +28 (+311.11%) | 0.00% | $0 M | Oct 29, 2026 |
| 66 | Tower Research Capital LLC (TRC) | 36 | -18,562 (-99.81%) | 0.00% | $0 M | Nov 16, 2026 |
| 67 | FMR LLC | 26 | +5 (+23.81%) | 0.00% | $0 M | Nov 10, 2026 |
| 68 | Physician Wealth Advisors, Inc. | 19 | 0 (0.00%) | 0.00% | $0 M | Oct 20, 2026 |
Mutual funds holding Owlet, Inc.#
| Fund | Shares | Value | Of the company | Of the fund | Change in shares | Report |
|---|---|---|---|---|---|---|
| 🇺🇸 JNL Multi-Manager Small Cap Growth FundJackson National Asset Management, LLC | 591,611 | $3 M | 2.0% | 0.13% | +32% | Jun 30, 2026 |
| 🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc. | 520,177 | $3 M | 1.8% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 Embark Small Cap Equity FundHarbor Capital Advisors, Inc. | 326,705 | $2 M | 1.1% | 0.27% | +41% | Jul 31, 2026 |
| 🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc. | 242,599 | $1 M | 0.83% | <0.01% | −0.4% | Jun 30, 2026 |
| 🇺🇸 Victory Small Cap Stock FundVictory Capital Management Inc. | 232,162 | $1 M | 0.79% | 0.12% | +34% | Jul 31, 2026 |
| 🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC | 97,972 | $1 M | 0.34% | <0.01% | +4.1% | May 31, 2026 |
| 🇺🇸 Acuitas US Microcap FundAcuitas Investments, LLC | 56,442 | $0 M | 0.19% | 0.27% | — | Jun 30, 2026 |
| 🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors | 55,892 | $0 M | 0.19% | 0.02% | +42% | Jun 30, 2026 |
| 🇺🇸 Global X Internet of Things ETFGlobal X Management Company LLC | 48,577 | $0 M | 0.17% | 0.11% | new | May 31, 2026 |
| 🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC | 39,726 | $0 M | 0.14% | <0.01% | no change | May 31, 2026 |
| 🇺🇸 Ultra-Small Company Market FundBridgeway Capital Management, LLC | 36,725 | $0 M | 0.13% | 0.14% | +158% | Jun 30, 2026 |
| 🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC | 33,623 | $0 M | 0.12% | <0.01% | +2.9% | May 31, 2026 |
| 🇺🇸 Dimensional U.S. Small Cap ETFDimensional Fund Advisors LP | 24,300 | $0 M | 0.08% | <0.01% | +48% | Jul 31, 2026 |
| 🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P. | 18,061 | $0 M | 0.06% | <0.01% | new | Jun 30, 2026 |
| 🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc. | 10,791 | $0 M | 0.04% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 U.S. Micro Cap PortfolioDimensional Fund Advisors LP | 11,221 | $0 M | 0.04% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 PACE Small/Medium Co Growth Equity InvestmentsUBS Asset Management (Americas) LLC | 11,071 | $0 M | 0.04% | 0.02% | no change | Jul 31, 2026 |
| 🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc. | 7,062 | $0 M | 0.02% | <0.01% | no change | Jun 30, 2026 |
| 🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC | 3,769 | $0 M | 0.01% | <0.01% | +36% | Jun 30, 2026 |
| 🇺🇸 U.S. Social Core Equity 2 PortfolioDimensional Fund Advisors LP | 3,758 | $0 M | 0.01% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Dimensional US Core Equity 1 ETFDimensional Fund Advisors LP | 2,884 | $0 M | <0.01% | <0.01% | new | Jul 31, 2026 |
| 🇺🇸 Dimensional U.S. Core Equity 2 ETFDimensional Fund Advisors LP | 2,466 | $0 M | <0.01% | <0.01% | no change | Jul 31, 2026 |
| 🇺🇸 Victory Extended Market Index FundVictory Capital Management Inc. | 1,693 | $0 M | <0.01% | <0.01% | −0.6% | Jul 31, 2026 |
| 🇺🇸 Total Stock Market Index TrustJohn Hancock Variable Trust Advisers LLC | 612 | $0 M | <0.01% | <0.01% | +13% | Jun 30, 2026 |
| 🇺🇸 Knights of Columbus U.S. ALL CAP INDEX FUNDKnights of Columbus Asset Advisors LLC | 96 | $0 M | <0.01% | <0.01% | +10% | Jul 31, 2026 |
Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 25 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.
Insider trading at Owlet, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Kurt WorkmanPresident & CEO | Shares withheld for tax | -20,400 | $4.890 | $100 K | 1.19 M | Form 4 |
| filed | Zane M. BurkeDirector | Grant or award | +26,785 | — | — | 134,787 | Form 4 |
| filed | Marc F. StollDirector | Grant or award | +26,785 | — | — | 45,781 | Form 4 |
| filed | Laura DurrDirector | Grant or award | +26,785 | — | — | 127,454 | Form 4 |
| filed | John C. KimDirector | Grant or award | +26,785 | — | — | 278,811 | Form 4 |
| filed | Melissa GonzalesDirector | Grant or award | +26,785 | — | — | 114,690 | Form 4 |
| filed | Kurt WorkmanPresident & CEO | Shares withheld for tax | -21,001 | $5.910 | $124 K | 1.21 M | Form 4 |
| filed | Kurt WorkmanPresident & CEO | Grant or award | +850,000 | — | — | 1.23 M | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Owlet, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Stock splits: 1-for-14.08 reverse split
Fails to deliver
- : 19 shares at $4.98
- : 12 shares at $4.88
- : 923 shares at $5.08
- : 856 shares at $5.79
- : 3,573 shares at $5.81
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Owlet, Inc. scorecard#
Passes 8 of the 17 checks that could be worked out. Fiscal year 2025; market cap of Aug 1, 2026.
Valuationnot known
- –P/E below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Price to book below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Price to sales below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
- –Free cash flow yield above 5%The market cap dates from 2026-08-01, more than 60 days ago.
- –Earnings yield above the 10-year Treasury yieldThe market cap dates from 2026-08-01, more than 60 days ago.
- –The price assumes slower growth than the last three years'The market cap dates from 2026-08-01, more than 60 days ago.
Growth3 of 6
- ✓Revenue grew in the newest year35.4%Revenue up 35.4% in fiscal 2025.
- ✓Revenue up more than 5% a year over three years15.2%15.2% a year over the three years to fiscal 2025.
- ✓Faster growth over three years than its peers' median15.2%15.2% a year against Medical Devices's median of 10.8% (73 companies).
- ✗Earnings per share grew in the newest year-2.27 vs -1.57Diluted EPS -2.27 in fiscal 2025 against -1.57 the year before (report's currency).
- ✗Net income higher than five years earlier-$40 M-$40 M in fiscal 2025 against -$11 M in 2020.
- ✗Revenue rose in at least four of the last five years3 of 5Revenue rose in 3 of the five years to fiscal 2025.
Profitability2 of 4
- ✗Profitable in the newest year-$40 MNet income -$40 M in fiscal 2025.
- ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2025.
- ✓Operating margin above its peers' median-7.8%-7.8% against Medical Devices's median of -8.2% (86 companies).
- –Return on equity above 15%No return on equity (equity missing or negative).
- –Return on invested capital above 10%No return on invested capital on file.
- ✓Operating margin wider than three years earlier-7.8%-7.8% in fiscal 2025 against -122.3% in 2022.
Financial health3 of 6
- ✓Short-term assets cover short-term liabilities1.9×Current ratio 1.85 at the end of fiscal 2025.
- ✓Debt below equity0.1×Debt to equity 0.13 at the end of fiscal 2025.
- ✓Net debt below three years of EBITDANet cashMore cash than debt: net cash of $33 M at the end of fiscal 2025.
- ✗Operating income covers interest five times-10.2×Operating income -10.2 times interest in fiscal 2025.
- ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
- ✗Altman Z-score outside the distress zone-1.26Z-score -1.26 (distress zone) for fiscal 2025.
Shareholder returns0 of 1
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- ✗Share count up no more than 2% in a year65.2%Diluted shares up 65.2% in fiscal 2025.
- –Dividends and buybacks above 3% of the market valueThe market cap dates from 2026-08-01, more than 60 days ago.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the medians of Medical Devices, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Financial analysis, 2025#
Worked out from Owlet, Inc.'s statements, beside the median of Medical Devices.
| Ratio | Trend | 2025 | Median of peers |
|---|---|---|---|
| Operating margin | -7.8% | -8.2% | |
| Net margin | -37.5% | -10.4% | |
| Revenue growth, 3 years a year | 15.2% | 10.8% | |
| Revenue growth | 35.4% | 10.4% | |
| Debt to equity | 0.13× | 0.64× | |
| Free cash flow margin | -10.5% | -1.9% |
4of 9on the Piotroski tests of financial strength
- Net loss of $40 million, the 6th loss-making year in a row.
- Free cash flow was negative: -$11 million.
- The share count rose 65.2% in the year.
- Operating income covers the interest bill only -10.2 times.
Owlet, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 | FY 2021to Dec 31, 2021 | FY 2020to Dec 31, 2020 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 106+35.4%100% | 78+44.5%100% | 54−22.0%100% | 69−8.8%100% | 76+0.6%100% | 75—100% | |
| Cost of revenue | 52+34.7%49.4% | 39+23.3%49.6% | 31−31.5%58.2% | 46+12.5%66.3% | 41+3.2%53.8% | 40—52.4% | |
| Gross profit | 54+36.2%50.6% | 39+74.0%50.4% | 23−3.1%41.8% | 23−33.5%33.7% | 35−2.3%46.2% | 36—47.6% | |
| Research and development | 14+43.6%13.3% | 9.8−5.3%12.6% | 10−62.9%19.2% | 28+30.2%40.3% | 21+105%28.3% | 10—13.9% | |
| Selling and marketing | 18+17.2%17.5% | 16+16.5%20.2% | 14−64.9%25.0% | 38+3.8%55.6% | 37+92.5%48.9% | 19—25.5% | |
| General and administrative | 29−13.9%27.7% | 34+24.2%43.5% | 27−34.2%50.6% | 42+28.5%60.0% | 32+146%42.6% | 13—17.4% | |
| Operating expenses | 62+3.8%58.5% | 60+16.2%76.3% | 51−52.5%94.8% | 108+18.8%156% | 91+112%120% | 43—56.9% | |
| Operating income | −8.3—−7.8% | −20—−25.9% | −29—−53.0% | −85—−122% | −56—−73.6% | −7.0—−9.3% | |
| Interest expense and finance costs | 0.8−50.4%0.8% | 1.6−48.9%2.1% | 3.2+189%5.9% | 1.1−37.7%1.6% | 1.8+28.2%2.3% | 1.4—1.8% | |
| Net interest income | — | −1.3—−1.7% | — | — | — | — | |
| Other non-operating income (expense) | −31−506%−29.7% | 7.7—9.9% | −4.3−180%−7.9% | 5.3—7.7% | −16—−20.9% | −3.5—−4.7% | |
| Income before tax | −40—−37.5% | −12—−16.0% | −33—−60.9% | −79—−115% | −72—−94.5% | −11—−13.9% | |
| Income tax | 0.0−48.1%0.0% | 0.1+440%0.1% | 0.0−65.5%0.0% | 0.0−6.5%0.0% | 0.0+55.0%0.0% | 0.0r0—0.0% | |
| Net income attributable to shareholders | −40—−37.5% | −13—−16.1% | −33—−60.9% | −79—−115% | −72—−94.5% | −11—−14.0% | |
| Earnings per share, basic | -2.31—— | -1.57—— | -4.53—— | -9.98r-0.71—— | -1.13—— | -0.48—— | |
| Earnings per share, diluted | -2.27—— | -1.57—— | -4.53—— | -9.98r-0.71—— | -1.13—— | -0.48—— | |
| Shares, weighted average (basic) | 18+65.2%— | 11+32.3%— | 8.3+4.1%— | 8.0r111−87.4%— | 63+188%— | 22—— | |
| Shares, weighted average (diluted) | 18+65.2%— | 11+32.3%— | 8.3+4.1%— | 8.0r111−87.4%— | 63+188%— | 22—— | |
| Balance sheet | |||||||
| Cash and cash equivalents | 35+75.2%41.4% | 20r20+22.3%40.9% | 17+47.4%37.5% | 11−88.2%19.3% | 95+459%67.9% | 17r1.3—42.4% | |
| Receivables | 23+89.5%26.8% | 12r12−13.4%24.5% | 14−12.4%31.7% | 16+52.4%27.5% | 10−0.5%7.5% | 11—26.2% | |
| Inventory | 15+45.3%17.9% | 11+62.1%21.3% | 6.5−64.9%14.7% | 19+3.0%31.9% | 18+127%12.8% | 7.9—19.7% | |
| Other current assets | 2.7−4.9%3.1% | 2.8−3.4%5.7% | 2.9−47.4%6.6% | 5.6−54.9%9.6% | 12+13140%8.8% | 0.1—0.2% | |
| Current assets | 82+77.8%95.7% | 46r46+15.4%93.1% | 40−22.1%90.5% | 51−62.3%88.2% | 136+261%97.0% | 38r1.6—93.8% | |
| Property, plant and equipment | 0.3+189%0.3% | 0.1−72.9%0.2% | 0.4−66.0%0.9% | 1.1−40.7%1.9% | 1.9+8.8%1.3% | 1.7—4.3% | |
| Right-of-use (leased) assets | 0.1−50.0%0.1% | 0.1−85.3%0.3% | 0.9−58.5%2.1% | 2.3—3.9% | 0—0.0% | — | |
| Other intangible assets | 1.4+42.7%1.6% | 1.0−55.9%2.0% | 2.2−3.0%5.0% | 2.3+34.4%3.9% | 1.7+180%1.2% | 0.6—1.5% | |
| Total assets | 86+73.1%100% | 49r50+12.1%100% | 44−24.1%100% | 58−58.5%100% | 140+249%100% | 40r232—100% | |
| Accounts payable | 12+6.1%14.0% | 11−17.5%22.8% | 14−55.1%31.0% | 30+9.6%52.4% | 28+69.5%19.8% | 16—40.8% | |
| Debt due within a year | 11+43.5%12.3% | 7.4−51.5%14.9% | 15r5.9+46.8%34.4% | 10+21.3%17.8% | 8.5+322%6.1% | 2.0—5.0% | |
| Current liabilities | 44+19.5%51.7% | 37r36−17.9%74.8% | 45−32.3%102% | 67−3.6%115% | 69+46.2%49.3% | 47r0.3—118% | |
| Long-term debt | 2.5−43.1%2.9% | 4.3—8.8% | 0—0.0% | 0−100%0.0% | 8.0−21.5%5.7% | 10—25.4% | |
| Lease liabilities (non-current) | 0.0−72.4%0.0% | 0.1+295%0.2% | 0.0−98.1%0.0% | 1.2—2.0% | 0—0.0% | — | |
| Total liabilities | 50−25.0%58.6% | 67r66−9.3%135% | 74+7.4%167% | 69−19.0%118% | 85+39.2%60.6% | 61r8.4—152% | |
| Retained earnings | −307r−308—−359% | −268r−268—−542% | −256—−579% | −223—−383% | −143—−102% | −72r−0.4—−179% | |
| Shareholders' equity | 19—22.2% | −30r−30—−61.4% | −38r−38—−85.6% | −11−119%−18.3% | 55—39.4% | −68r5.0—−170% | |
| Total liabilities and equity | 86+73.1%100% | 49r50+12.1%100% | 44−24.1%100% | 58−58.5%100% | 140+249%100% | 40r232—100% | |
| Shares outstanding | 27+71.3%— | 16+78.8%— | 8.8+6.7%— | 8.2r115−92.7%— | 113+411%— | 22—— | |
| Cash-flow statement | |||||||
| Depreciation and amortization | 0.5+15.3%0.5% | 0.5−46.3%0.6% | 0.8−40.6%1.6% | 1.4+25.2%2.0% | 1.1+29.8%1.5% | 0.9—1.2% | |
| Share-based compensation | 9.3+8.3%8.8% | 8.6−13.1%11.1% | 9.9−22.7%18.4% | 13+202%18.6% | 4.3+298%5.6% | 1.1—1.4% | |
| Cash from operating activities | −11—−10.2% | −11—−14.4% | −24—−43.6% | −81—−118% | −41—−53.5% | −0.1—−0.2% | |
| Capital expenditure | −0.3—−0.3% | −0.0—−0.0% | −0.0—−0.0% | −0.6—−0.9% | −1.0—−1.3% | −1.0—−1.3% | |
| Intangible assets bought | −0.1—−0.1% | −0.1—−0.1% | −0.0—−0.1% | −0.9—−1.3% | −1.1—−1.4% | −0.1—−0.1% | |
| Cash from investing activities | −0.9—−0.9% | −0.8—−1.0% | −0.1—−0.1% | −1.6—−2.3% | −2.0—−2.7% | −1.1—−1.4% | |
| Debt issued | — | — | 0.5—0.9% | 0−100%0.0% | 5.0+66.7%6.6% | 3.0—4.0% | |
| Debt repaid | −0.5—−0.5% | −5.0—−6.4% | −3.5—−6.5% | −6.0—−8.7% | −1.0—−1.3% | 0—0.0% | |
| Shares issued | 32+203%30.4% | 11r10—13.6% | 0—0.0% | — | — | — | |
| Cash from financing activities | 32+100%30.4% | 16−44.5%20.6% | 29—53.5% | −0.9−101%−1.3% | 121+1768%159% | 6.5—8.6% | |
| Change in cash | 20+400%19.3% | 4.1−23.5%5.2% | 5.3—9.9% | −84−207%−121% | 78+1380%103% | 5.3—7.0% | |
| Report | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q4 FY2024to Dec 31, 2024 | Q3 FY2024to Sep 30, 2024 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Revenue | 113+12.7%100% | 30−4.9%100% | 34+29.9%100% | 22+4.2%100% | 26r27*+27.4%100% | 32+44.6%100% | 26+25.9%100% | 22r21+46.1%100% | 20*−2.5%100% | 22—100% | 21—100% | 15—100% | 21*—100% | |
| Cost of revenue | 50+5.2%44.5% | 14−11.0%46.2% | 12−5.1%35.6% | 10+4.5%45.5% | 14*+46.3%53.4% | 16+49.3%49.4% | 13+21.4%48.7% | 9.8+19.2%45.4% | 9.5*−14.5%46.5% | 11—47.8% | 10—50.5% | 8.2—55.6% | 11*—53.0% | |
| Gross profit | 63+19.7%55.5% | 16+1.1%53.8% | 22+63.1%64.4% | 12+3.9%54.5% | 12r13*+11.1%46.6% | 16+40.3%50.6% | 13+30.5%51.3% | 12r11+79.9%54.6% | 11*+11.1%53.5% | 12—52.2% | 10—49.5% | 6.5—44.4% | 9.9*—47.0% | |
| Research and development | 16+22.1%14.0% | 3.6−4.8%11.8% | 4.6+22.4%13.5% | 3.9r4.0+36.2%17.5% | 3.7r3.6*+45.6%14.2% | 3.8r3.8+47.2%11.8% | 3.7r3.8+58.4%14.3% | 2.9r2.9+22.7%13.4% | 2.5*+11.1%12.4% | 2.6—11.6% | 2.4—11.4% | 2.3—15.9% | 2.3*—10.9% | |
| Selling and marketing | 20+17.5%17.9% | 4.6−7.0%15.1% | 6.0+37.9%17.6% | 4.5r4.5+11.8%19.9% | 5.2r5.2*+31.2%20.1% | 4.9r4.9+22.4%15.4% | 4.3r4.3+12.0%16.6% | 4.0r4.0+2.7%18.6% | 4.0*+6.1%19.5% | 4.0—18.2% | 3.9—18.6% | 3.9—26.4% | 3.8*—17.9% | |
| General and administrative | 35+8.0%30.8% | 7.0+12.3%23.0% | 9.6+36.3%28.3% | 9.2r9.3+30.9%41.2% | 8.9r8.7*−24.7%34.2% | 6.2r6.3−36.2%19.5% | 7.0r7.2+11.6%26.9% | 7.1r7.1+16.8%32.8% | 12*+71.5%57.8% | 9.8—44.2% | 6.3—30.4% | 6.1—41.0% | 6.9*—32.9% | |
| Operating expenses | 71+13.5%62.7% | 15+1.6%49.9% | 20+33.3%59.3% | 18r18+26.5%78.6% | 18r18*−2.8%68.4% | 15r15−8.8%46.7% | 15r15+20.5%57.8% | 14r14+13.4%64.7% | 18*+41.8%89.7% | 16—74.0% | 12—60.4% | 12—83.3% | 13*—61.7% | |
| Operating income | −8.1—−7.2% | 1.2−5.3%4.0% | 1.7—5.1% | −5.4r−5.5—−24.1% | −5.7r−4.9*—−21.8% | 1.3r1.2—4.0% | −1.7r−1.9—−6.5% | −2.2r−2.7—−10.1% | −7.4*—−36.2% | −4.8—−21.8% | −2.2—−10.8% | −5.7—−39.0% | −3.1*—−14.7% | |
| Interest expense and finance costs | 0.0−96.6%0.0% | 0−100%0.0% | 0−100%0.0% | 0−100%0.0% | 0.0*−92.5%0.2% | 0.1−30.1%0.3% | 0.3—1.1% | 0.4+139%1.8% | 0.6*+225%3.1% | 0.1—0.6% | −0.0—−0.1% | 0.2—1.1% | 0.2*—0.9% | |
| Net interest income | — | 0.1—0.2% | −0.7—−2.1% | −0.7—−3.0% | — | −0.9—−2.7% | −1.0−4995%−3.8% | −1.0—−4.6% | −1.1*—−5.1% | −0.1—−0.5% | 0.0—0.1% | −0.2—−1.1% | — | |
| Other non-operating income (expense) | −4.3—−3.8% | 0.3−91.5%0.8% | −2.4—−6.9% | 2.2−62.1%9.6% | −4.3*—−16.6% | 2.9—9.2% | −36−3290%−137% | 5.7−36.7%26.5% | −1.6*—−7.9% | −0.8—−3.6% | 1.1—5.4% | 9.0—61.2% | −3.8*—−18.3% | |
| Income before tax | −12—−11.0% | 1.5−65.4%4.8% | −0.6—−1.8% | −3.2r−3.3−192%−14.4% | −10r−9.2*—−38.3% | 4.2r4.1—13.1% | −37r−38—−143% | 3.5r3.0+8.1%16.4% | −9.0*—−44.0% | −5.6—−25.4% | −1.1—−5.4% | 3.3—22.2% | −6.9*—−33.0% | |
| Income tax | 0.0−77.9%0.0% | 0.0+211%0.1% | 0.0−69.7%0.0% | 0.0−41.7%0.0% | −0.0*−181%−0.1% | 0.0—0.0% | 0.0+50.0%0.1% | 0.0—0.1% | 0.0*+540%0.2% | 0—0.0% | 0.0—0.1% | 0—0.0% | 0.0*—0.0% | |
| Net income attributable to shareholders | −12—−10.3% | 1.4−66.0%4.7% | −0.6—−1.8% | −3.2r−3.3−192%−14.5% | −9.1—−35.0% | 4.2r4.1—13.1% | −37r−38—−144% | 3.5r3.0+7.7%16.4% | −9.1*—−44.2% | −5.6—−25.4% | −1.1—−5.5% | 3.3—22.2% | −6.9*—−33.0% | |
| Earnings per share, basic | — | 0.02−88.2%— | -0.05—— | -0.15−207%— | — | 0.17—— | -2.35r-2.37—— | 0.14r0.11−6.7%— | — | -0.61—— | -0.30—— | 0.15—— | — | |
| Earnings per share, diluted | — | 0.01—— | -0.05—— | -0.24r-0.25−271%— | — | -0.05r-0.06—— | -2.35r-2.37—— | 0.14r0.11—— | — | -0.61—— | -0.30—— | -0.51—— | — | |
| Shares, weighted average (basic) | 29+78.0%— | 29+78.0%— | 29+81.4%— | 27+78.2%— | — | 16+46.7%— | 16+77.2%— | 15+76.0%— | — | 11—— | 8.9—— | 8.7—— | — | |
| Shares, weighted average (diluted) | 30+53.1%— | 30+53.1%— | 29+81.4%— | 28+79.2%— | — | 19+74.9%— | 16+77.2%— | 15+59.9%— | — | 11—— | 8.9—— | 9.6—— | — | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 32—36.9% | 32+33.1%36.9% | 31+41.8%33.1% | 35+117%40.9% | 35+75.2%41.4% | 24+10.1%31.7% | 22+42.1%34.3% | 16−11.3%31.7% | 20r20+22.3%40.9% | 22r22—38.5% | 15—33.5% | 18—42.0% | 17—37.5% | |
| Receivables | 29—33.4% | 29+0.3%33.4% | 33+35.9%35.4% | 20+20.2%22.9% | 23+89.5%26.8% | 29+66.6%38.2% | 24+44.3%38.4% | 17+42.5%32.2% | 12r12−13.4%24.5% | 17—30.6% | 17—36.8% | 12—26.5% | 14—31.7% | |
| Inventory | 16—19.0% | 16+12.0%19.0% | 16+37.6%16.7% | 18+54.0%21.0% | 15+45.3%17.9% | 15+37.1%19.4% | 11+40.5%17.9% | 12+52.7%23.0% | 11+62.1%21.3% | 11—18.9% | 8.1—17.7% | 7.7—17.7% | 6.5—14.7% | |
| Other current assets | 3.3—3.9% | 3.3−25.8%3.9% | 3.0+4.4%3.2% | 3.4−2.2%3.9% | 2.7−4.9%3.1% | 4.5+63.9%6.0% | 2.9+32.0%4.5% | 3.5+51.5%6.7% | 2.8−3.4%5.7% | 2.7—4.9% | 2.2—4.7% | 2.3—5.2% | 2.9—6.6% | |
| Current assets | 80—93.6% | 80+11.9%93.6% | 88+45.4%94.4% | 82+70.3%95.0% | 82+77.8%95.7% | 72+37.0%95.7% | 61+42.8%95.6% | 48+21.0%94.2% | 46r46+15.4%93.1% | 52—93.1% | 43—92.7% | 40—91.3% | 40—90.5% | |
| Property, plant and equipment | 1.2—1.4% | 1.2+303%1.4% | 0.8+344%0.9% | 0.7+627%0.8% | 0.3+189%0.3% | 0.3+90.8%0.4% | 0.2−3.6%0.3% | 0.1−65.1%0.2% | 0.1−72.9%0.2% | 0.2—0.3% | 0.2—0.4% | 0.3—0.6% | 0.4—0.9% | |
| Right-of-use (leased) assets | — | — | — | — | 0.1−50.0%0.1% | 0.1+22.4%0.1% | 0.1−55.8%0.2% | 0.1−81.2%0.2% | 0.1−85.3%0.3% | 0.1—0.1% | 0.2—0.5% | 0.6—1.3% | 0.9—2.1% | |
| Other intangible assets | 2.1—2.4% | 2.1+69.7%2.4% | 2.0+107%2.2% | 1.7+66.6%2.0% | 1.4+42.7%1.6% | 1.2+39.8%1.6% | 1.0−56.1%1.5% | 1.0−52.5%2.0% | 1.0−55.9%2.0% | 0.9—1.5% | 2.2—4.8% | 2.2—5.0% | 2.2—5.0% | |
| Total assets | 86—100% | 86+14.4%100% | 94+47.3%100% | 87+68.8%100% | 86+73.1%100% | 75+33.4%100% | 64+38.5%100% | 51+17.3%100% | 49r50+12.1%100% | 56—100% | 46—100% | 44—100% | 44—100% | |
| Accounts payable | 12—14.0% | 12−32.1%14.0% | 12−5.9%13.0% | 12−7.3%13.6% | 12+6.1%14.0% | 18+53.3%23.6% | 13−26.3%20.3% | 13−20.9%24.7% | 11−17.5%22.8% | 12—20.5% | 18—38.2% | 16—36.7% | 14—31.0% | |
| Debt due within a year | 11—12.9% | 11−50.0%12.9% | 17−0.6%18.2% | 17+67.3%19.4% | 11+43.5%12.3% | 22+113%29.4% | 17+714%27.0% | 10+149%19.6% | 7.4−51.5%14.9% | 10—18.4% | 2.1—4.6% | 4.0—9.2% | 15r5.9—34.4% | |
| Current liabilities | 42—48.9% | 42−33.4%48.9% | 54+2.0%57.5% | 48+17.8%55.5% | 44+19.5%51.7% | 63+76.3%84.1% | 53+25.3%83.1% | 41r41+3.6%79.5% | 37r36−17.9%74.8% | 36—63.6% | 42—91.8% | 39—90.0% | 45—102% | |
| Long-term debt | 0—0.0% | 0−100%0.0% | 0−100%0.0% | 2.0−49.3%2.2% | 2.5−43.1%2.9% | 2.9−36.2%3.9% | 3.4—5.3% | 3.8—7.5% | 4.3—8.8% | 4.6—8.2% | 0—0.0% | 0—0.0% | 0—0.0% | |
| Lease liabilities (non-current) | — | — | — | — | 0.0−72.4%0.0% | — | — | — | 0.1+295%0.2% | — | — | — | 0.0—0.0% | |
| Total liabilities | 43—49.8% | 43−62.4%49.8% | 55−49.3%58.5% | 51−19.9%58.7% | 50−25.0%58.6% | 113+73.2%152% | 108+61.9%170% | 64r63−3.1%124% | 67r66−9.3%135% | 66—117% | 67—145% | 66—150% | 74—167% | |
| Retained earnings | −310—−361% | −310—−361% | −311—−332% | −310r−311—−358% | −307r−308—−359% | −298r−299—−398% | −302r−303—−476% | −265r−265—−515% | −268r−268—−542% | −259—−462% | −254—−552% | −252—−576% | −256—−579% | |
| Shareholders' equity | 26—30.9% | 26—30.9% | 23—24.7% | 21—24.2% | 19—22.2% | −54—−72.3% | −59—−93.1% | −26r−26—−50.6% | −30r−30—−61.4% | −21—−38.2% | −33—−72.8% | −33—−75.1% | −38r−38—−85.6% | |
| Total liabilities and equity | 86—100% | 86+14.4%100% | 94+47.3%100% | 87+68.8%100% | 86+73.1%100% | 75+33.4%100% | 64+38.5%100% | 51+17.3%100% | 49r50+12.1%100% | 56—100% | 46—100% | 44—100% | 44—100% | |
| Shares outstanding | 29—— | 29+75.7%— | 29+77.2%— | 28+77.7%— | 27+71.3%— | 17+7.2%— | 16+78.7%— | 16+75.4%— | 16+78.8%— | 15—— | 9.1—— | 9.0—— | 8.8—— | |
| Cash-flow statement | ||||||||||||||
| Depreciation and amortization | 0.8+71.5%0.7% | 0.3*+109%1.0% | 0.2*+93.6%0.6% | 0.2+55.5%0.8% | 0.2*+24.6%0.6% | 0.1*+20.5%0.4% | 0.1*+4.8%0.4% | 0.1+9.2%0.6% | 0.1*−10.3%0.6% | 0.1*—0.5% | 0.1*—0.5% | 0.1—0.7% | 0.1*—0.6% | |
| Share-based compensation | 14+141%12.8% | 2.6+116%8.6% | 3.3+116%9.8% | 3.5+111%15.5% | 5.0r4.8*+215%19.1% | 1.2r1.3−55.1%3.8% | 1.5r1.6−26.9%5.9% | 1.7−25.6%7.7% | 1.6*−30.7%7.7% | 2.7—12.3% | 2.1—10.2% | 2.2—15.1% | 2.3*—10.9% | |
| Cash from operating activities | −3.4—−3.0% | 2.2*—7.2% | −0.1*—−0.3% | −5.0—−22.5% | −0.5*−115%−1.7% | −2.2*—−6.8% | −2.2*—−8.6% | −5.9—−27.5% | 3.0*—14.7% | −7.5r−7.9*—−33.9% | −3.4r−3.3*—−16.3% | −3.4r−3.3—−22.8% | −1.6*—−7.5% | |
| Capital expenditure | −1.1—−1.0% | −0.4*—−1.2% | −0.5*—−1.6% | −0.0—−0.1% | −0.2*—−0.8% | −0.0*—−0.0% | −0.1*—−0.2% | −0.0—−0.0% | −0.0*—−0.2% | — | −0.0*—−0.0% | 0—0.0% | −0.0*—−0.0% | |
| Intangible assets bought | −0.2—−0.2% | −0.1*—−0.3% | −0.1*—−0.2% | −0.0—−0.1% | −0.1*—−0.2% | −0.0*—−0.1% | −0.0*—−0.1% | 0—0.0% | — | −0.0r−0.1*—−0.1% | −0.0r−0.1*—−0.2% | −0.0r−0.1—−0.3% | −0.0*—−0.1% | |
| Cash from investing activities | −2.5—−2.2% | −0.7*—−2.2% | −0.9*—−2.8% | −0.4—−1.8% | −0.5*—−1.9% | −0.3*—−0.8% | −0.1*—−0.3% | −0.1—−0.5% | −0.2*—−0.8% | −0.5r−0.6*—−2.3% | −0.0r−0.1*—−0.2% | −0.0r−0.1—−0.3% | −0.0*—−0.1% | |
| Debt issued | — | — | — | — | — | — | — | — | — | — | — | — | 0*—0.0% | |
| Debt repaid | −8.0—−7.1% | 0*—0.0% | −6.8*—−20.0% | −0.8—−3.4% | −0.5*—−1.9% | 0*—0.0% | 0*—0.0% | 0—0.0% | 0*—0.0% | −2.0*—−9.0% | −1.5*—−7.2% | −1.5—−10.2% | −1.5*—−7.1% | |
| Shares issued | — | — | — | — | 32*+103477%123% | — | — | — | 0.0r−0.6*—0.2% | — | — | — | 0*—0.0% | |
| Cash from financing activities | 14+35.9%12.2% | −6.1*−241%−20.2% | −3.4*−144%−10.1% | 5.5+171%24.3% | 18*—68.5% | 4.4*−70.0%13.6% | 7.9*+2033%30.1% | 2.0−61.5%9.3% | −4.1*−236%−19.9% | 15r15*—65.7% | 0.4*—1.8% | 5.2—35.5% | 3.0*—14.3% | |
| Change in cash | 7.9+261%7.0% | −4.6*−339%−15.2% | −4.5*−181%−13.2% | −0.0—−0.0% | 17*—64.9% | 1.9*−70.3%6.0% | 5.5*—21.2% | −4.0−319%−18.7% | −1.3*−190%−6.1% | 6.5*—29.5% | −3.0*—−14.7% | 1.8—12.5% | 1.4*—6.6% | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
What Owlet, Inc. sells: revenue by product line, fiscal 2025#
As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.
Source: SEC annual report (XBRL data) · as of Dec 31, 2025
Where Owlet, Inc. operates: 2 countries#
Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue.
Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided
Executive pay at Owlet, Inc.#
From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.
| Fiscal year | CEO total pay | Actually paid | Other executives, average | $100 invested |
|---|---|---|---|---|
| 2025Kurt Workman | $4.2 M | $7.7 M | $2.4 M | $207 |
| 2024Kurt Workman | $987 K | $920 K | $1.1 M | $57 |
| 2023Kurt Workman | $269 K | −$88 K | $687 K | $67 |
Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025
Events at Owlet, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.
Directors and officers 7 · Material agreement 6 · New debt 2 · Unregistered share sale 3 · Bylaws or fiscal year changed 2 · Shareholder vote 3 · Results announced 10
| Filed | What happened | Filing |
|---|---|---|
| Directors and officersShareholder vote | 8-K | |
| Results announced | 8-K | |
| Material agreementNew debt | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Directors and officersBylaws or fiscal year changedShareholder vote | 8-K | |
| Directors and officers | 8-K | |
| Material agreementUnregistered share sale | 8-K/A | |
| Material agreementUnregistered share sale | 8-K | |
| Directors and officersResults announced | 8-K | |
| Material agreement | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Results announced | 8-K | |
| Bylaws or fiscal year changed | 8-K | |
| Material agreement | 8-K | |
| Material agreementNew debtUnregistered share sale | 8-K | |
| Directors and officersShareholder vote | 8-K | |
| Results announced | 8-K | |
| Directors and officers | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Aug 14, 2026
From US state WARN notices and SEC 8-K restructuring filings, newest first.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022 | · | · | · | · | · | · | 74 | · | · | · | · | · | 74 |
| Announced | People | Kind | Where | Source |
|---|---|---|---|---|
| 74 people | Restructuring planSEC 8-K | “As part of the restructuring program implementation, the Company commenced a workforce reduction of approximately 74 employees that is expected to be substantially completed in the…” | Filing |
Source: State WARN notices and SEC 8-K item 2.05
How Owlet, Inc. compares in Medical Devices
- Market cap$194 M · higher than 41% of 142
- Revenue$106 M · higher than 43% of 155
- Net margin-8.4% · higher than 48% of 144
- Revenue growth35.4% · higher than 87% of 104
- Price / sales1.7× · lower than 69% of 96
- Price / book10.2× · lower than 14% of 99
- FCF yield-5.7% · higher than 39% of 76
Peer comparison · Medical Devices
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Owlet, Inc.🇺🇸 | $194 M | — | -8.4% | +35.4% |
| Abbott Laboratories🇺🇸 | $181.1 B | 38.5× | 9.8% | +5.7% |
| Medtronic plc🇺🇸 | $121.2 B | 23.2× | 13.9% | +8.4% |
| Stryker Corporation🇺🇸 | $116.5 B | 32.2× | 13.8% | +11.2% |
| Boston Scientific Corporation🇺🇸 | $66.2 B | 18.9× | 16.6% | +19.9% |
| Edwards Lifesciences Corporation🇺🇸 | $52.8 B | 51.7× | 15.3% | +11.6% |
| Shenzhen Mindray Bio-Medical Electronics Co., Ltd.🇨🇳 | $27.8 B | 23.6× | 24.4% | — |
| STERIS plc🇮🇪 | $20.4 B | 24.6× | 13.4% | +8.7% |
| Zimmer Biomet Holdings, Inc.🇺🇸 | $18.2 B | 23.8× | 8.9% | +7.2% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- RxSight, Inc.$195 M
- United Orthopedic Corporation$206 M
- Easywell Biomedicals, Inc.$181 M
- Inogen, Inc.$173 M
- Hi-Clearance Inc.$169 M
- Delta Asia International Corporation$162 M
Sources and freshness
- Market cap:
- Aug 1, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Employees:
- As of December 31, 2025
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Owlet, Inc.? Verify and update this profile — free
Show Owlet, Inc.'s ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.